IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:IntegraGen SA (ALINT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7283
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, genomic research tools and solutions to microbiologic researchers. It also offers DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis and bioinformatics analysis of sequence data services, among others. IntegraGen develops miR-31-3p, a microRNA biomarker for metastatic colorectal and lung cancer. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics and agriculture. It caters to patients, clinicians and researchers. The company has operations in France and the US. IntegraGen is headquartered in Paris, France.

IntegraGen SA (ALINT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
IntegraGen SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
IntegraGen SA, Medical Equipment, Deal Details 10
Partnerships 10
GoPath Labs Enters into Licensing Agreement with IntegraGen 10
Laboratoire CERBA Enters into Licensing Agreement with IntegraGen 11
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 12
IntegraGen Enters into Distribution Agreement with Twist Bioscience 14
Lab21 Enters Into Agreement With IntegraGen To Develop Cancer Diagnostic 15
Equity Offering 16
IntegraGen Raises USD4 Million in Private Placement of Shares 16
IntegraGen Completes Private Placement Of Shares For US$2.5 Million 17
IntegraGen SA – Key Competitors 18
IntegraGen SA – Key Employees 19
IntegraGen SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Sep 20, 2018: Integragen announces 17% increase in sales revenue and a 57% increase in operating profit for the first half of 2018 21
Apr 13, 2018: IntegraGen Reports 2017 Annual Results 23
Jan 09, 2018: IntegraGen Reports 2017 revenue and cash position 25
Sep 29, 2017: IntegraGen Reports Financial Results for 1st Half of 2017 26
Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017 28
Apr 21, 2017: IntegraGen Announces 2016 Annual Results: Increase in operating revenues and significant improvement in operating income (+22%) 29
Jan 09, 2017: IntegraGen Reports Sharp Increase in Sales During 2016 32
Legal and Regulatory 33
Apr 23, 2018: IntegraGen Achieves ISO 13485:2016 Certification for the Design, Manufacturing and Distribution of In Vitro Diagnostic Kits 33
Other Significant Developments 34
Jan 18, 2018: IntegraGen Launches SIRIUS and MERCURY – Big Data Tools Which Enable Ultra-Efficient Exploration of Large-Scale Genomic Data 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
IntegraGen SA, Medical Equipment, Key Facts, 2017 2
IntegraGen SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Deals By Market, 2012 to YTD 2018 8
IntegraGen SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GoPath Labs Enters into Licensing Agreement with IntegraGen 10
Laboratoire CERBA Enters into Licensing Agreement with IntegraGen 11
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 12
IntegraGen Enters into Distribution Agreement with Twist Bioscience 14
Lab21 Enters Into Agreement With IntegraGen To Develop Cancer Diagnostic 15
IntegraGen Raises USD4 Million in Private Placement of Shares 16
IntegraGen Completes Private Placement Of Shares For US$2.5 Million 17
IntegraGen SA, Key Competitors 18
IntegraGen SA, Key Employees 19
IntegraGen SA, Subsidiaries 20

List of Figures
IntegraGen SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
IntegraGen SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
IntegraGen SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Linde AG (LIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. It offers a wide range of compressed, liquefied gases and chemicals. It also offers engineeri …
  • Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Piller Group GmbH:企業の戦略的SWOT分析
    Piller Group GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Sanochemia Pharmazeutika AG (SAC):企業の財務・戦略的SWOT分析
    Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Verdezyne Inc-製薬・医療分野:企業M&A・提携分析
    Summary Verdezyne Inc (Verdezyne) is an industrial biotechnology company that develops and produces chemicals from renewable and non-food sources. The company’s products include adipic acid, dodecanedioic acid and sebacic acid. Its products are used in production of toothbrush bristles and fishing l …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Warner Media LLC.:企業の戦略・SWOT・財務情報
    Warner Media LLC. - Strategy, SWOT and Corporate Finance Report Summary Warner Media LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Malayan Banking Berhad:企業の戦略・SWOT・財務情報
    Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fresenius Kabi USA LLC-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically il …
  • Fresenius SE & Co KGaA (FRE)-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biofortuna Ltd:企業の製品パイプライン分析2018
    Summary Biofortuna Ltd (Biofortuna) is a provider of contract services and molecular diagnostic products. The company distributes CE-marked and freeze-dried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogene …
  • Capitol Health Ltd (CAJ):企業の財務・戦略的SWOT分析
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, mammography, nuclear medic …
  • Orthofix International N.V. (OFIX)-医療機器分野:企業M&A・提携分析
    Summary Orthofix International N.V. (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic. Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation prod …
  • The Miyazaki Taiyo Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • AnaptysBio Inc (ANAB):製薬・医療:M&Aディール及び事業提携情報
    Summary AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody product candidates for the treatment of inflammatory, autoimmune and atopic diseases. The company develops its product candidates through its proprietary antibody discovery techn …
  • Bajaj Finserv Limited:企業の戦略・SWOT・財務情報
    Bajaj Finserv Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Finserv Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆